Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 7/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 6/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | TP53 | P04637 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 5/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.54 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.53 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.51 |
| ▸ | GPR119 | Q8TDV5 | 4/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18831899 | 0.83 | USP2 (0.58) | MAPK1CYP3A4ALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL21946732 | 0.80 | MAPK1 (0.54) | MAPK1CYP3A4ALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL485724 | 0.80 | MAPK1 (0.54) | MAPK1CYP3A4ALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL26101978 | 0.80 | MAPK1 (0.54) | MAPK1CYP3A4ALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL1779228 | 0.80 | SMN1; SMN2 (0.57) | MAPK1CYP3A4ALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL24793978 | 0.80 | ALDH1A1 (0.48) | MAPK1CYP3A4ALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL29709652 | 0.80 | ALDH1A1 (0.48) | MAPK1CYP3A4ALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL484899 | 0.79 | CYP11B2 (0.60) | MAPK1CYP3A4ALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL31091690 | 0.79 | HDAC2 (0.52) | MAPK1CYP3A4ALDH1A1SMN1; SMN2TSHR | |
| SCHEMBL30831047 | 0.79 | GPR119 (0.50) | MAPK1CYP3A4ALDH1A1SMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7943630-B2 | 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors | NEUROSEARCH A/S (DK) | 2011-05-17 | — | — | US | disclosed |
| EP-1917264-B1 | NOVEL 3,9-DIAZA-SPIRO[5.5]UNDECANE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS | NEUROSEARCH AS (DK) | 2010-11-17 | — | — | EP | disclosed |
| US-20090111841-A1 | Novel 3,9-Diaza-Spiro[5,5]Undecane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors | ANIONA APS (DK) | 2009-04-30 | — | — | US | disclosed |
| EP-1917264-A1 | NOVEL 3,9-DIAZA-SPIRO[5.5]UNDECANE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS | NeuroSearch A/S (DK) | 2008-05-07 | — | — | EP | disclosed |
| WO-2007000463-A1 | NOVEL 3,9-DIAZA-SPIRO[5.5]UNDECANE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS | NEUROSEARCH A/S (DK) | 2007-01-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090111841-A1 | Novel 3,9-Diaza-Spiro[5,5]Undecane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors | SLC18A2, SLC6A2, SLC6A3 | MAPK1 3840/4885CYP3A4 664/4885ALDH1A1 346/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.